These compounds, Abacavir Sulfate, Abarelix, and Abiraterone Acetate, each possess distinct chemical architectures leading to their varying pharmacological functions. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, is readily identified via its molecular formula – C14H15N6O4·H2SO4 – and characteristic radiant properties observed in techniques such as mass spectrometry and infrared analysis. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor inhibitor, presents with a complex peptide sequence, typically requiring amino acid sequencing and peptide mapping for complete identification. Finally, Abiraterone Acetate, a CYP17 inhibitor utilized in prostate cancer treatment, can be verified through its particular mass and fragmentation patterns acquired through gas chromatography-mass spectrometry (GC-MS) alongside nuclear magnetic resonance (NMR) investigative data, ensuring its accurate chemical characterization.
Directory: Abacavir Sulfate Sulfate (CAS 188062-50-2) & Related Substances
Explore our extensive catalogue detailing Abacavir Sulfate, identified by CAS number 188062-50-2, and a selection of associated materials. We provision includes several grades to meet precise research and creation demands. You'll detailed information including analytical results and stock containers options. Additionally, examine our array of structurally akin substances that could be helpful in the ongoing project. Our directory is structured to assist streamlined procurement of high-quality pharmaceutical materials.
Drug Reference: Abarelex and Abiraterone Acetate Chemical Abstract Service Numbers
For chemists and drug professionals seeking precise drug identification, precise CAS numbers are vital. Specifically, abarelix, a gonadotropin-releasing-releasing hormone modulator used in treating prostate tumors, is designated the Registry identifier 65572-21-8. Furthermore, abiraterone acetate, a key drug in advanced cancer, carries the Chemical Abstract Service code 389292-17-3. Thorough notation and confirmation of these Registry identifiers are critical to ensure correct substance assessment and following operations. Such numbers are widely obtainable through multiple scientific repositories. Regularly consult recognized data for the current data.
Pharmaceutical Ingredients: Abacavir Sulfate, Abarelix, Abiraterone Acetate Acetate, Registry Listings
The determination of critical pharmaceutical ingredients often relies on precise chemical references. In particular, this article succinctly examines three important instances: Abacavir, a pyrimidine reverse polymerase inhibitor; , a hormone antagonist; and Abiraterone, utilized in malignant management. Each substance is connected with a unique CAS number, offering a universal method for tracking details and verifying accurate communication within the pharmaceutical community. View the respective databases for complete records and associated data.
CAS Registry Number Database: Entries for Abacavir Sulfate, Abarelix, Abiraterone Acetate
The comprehensive Chemical Abstracts Service (CAS) registry is an essential resource for chemists and pharmaceutical professionals alike. This section briefly details records pertaining to three important medicinal compounds: Abacavir Sulfate Salt, a drug used to treat HIV; Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist used in prostate cancer; and Abiraterone Acetate, a powerful medication administered in the treatment of metastatic aggressive cancer. Finding the accurate CAS number for each molecule allows for unambiguous identification and supports precise literature searching. These unique identifiers are vital for data validation and uniform communication across the ALMOTRIPTAN MALEATE 181183-52-8 industry.
Leveraging API Substance Data: Item Recognition with CAS Numbers
Accurate compound identification is essential in the material industry, and Application Programming Interface material data provides a robust answer. In particular, CAS numbers act as unique identifiers for material substances, enabling seamless consolidation with collections and platforms. This kind of technique not only enhances records accuracy but also simplifies procedures related to research, procurement, and compliance documentation. Furthermore, obtaining this information via an Application Programming Interface promotes efficiency and reduces the potential for operator oversight.